Financial News

Ohr presents additional positive study data

Ohr Pharmaceutical Inc. (Nasdaq: OHRP) presented additional positive data from the IMPACT study interim analysis at the 38th Annual Macula Society Meeting. The stock price leaped $2.09 to close at $9.78.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback